Anders Fink-Jensen

Anders Fink-Jensen

Clinical Professor

Member of:

  • Psychiatry


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2024
  2. Published

    Efficacy and safety of semaglutide 2.4 mg according to antidepressant use at baseline: A post hoc subgroup analysis

    Kushner, R. F., Fink-Jensen, Anders, Frenkel, O., McGowan, B., Goldman, B., Overvad, M. & Wadden, T., 2024, In: Obesity. 32, 2, p. 273-280 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. E-pub ahead of print

    Liraglutide 3.0 mg once daily for the treatment of overweight and obesity in patients hospitalised at a forensic psychiatric department: A 26-week open-label feasibility study

    Sass, M. R., Christensen, A. M. B., Christensen, M. L., Gruber, E., Nerdrum, H., Pedersen, L. M., Resch, M., Jørgensen, T. H., Ekstrøm, Claus Thorn, Nielsen, Jimmi, Vilsbøll, Tina & Fink-Jensen, Anders, 2024, (E-pub ahead of print) In: Acta Psychiatrica Scandinavica.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Virtual reality-assisted cognitive behavioral therapy for patients with alcohol use disorder: a randomized feasibility study

    Thaysen-Petersen, D., Hammerum, S. K., Vissing, A., Oestrich, I. H., Nordentoft, Merete, Düring, S. W. & Fink-Jensen, Anders, 2024, In: Frontiers in Psychiatry. 15, 12 p., 1337898.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 916366